NewSquare Capital’s Avanos Medical AVNS Stock Holding History

NewSquare Capital’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-23	Closed	-$282	–	267
2025 Q2	$282	Buy	+23	New	+$289	﹤0.01%	1205

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

NewSquare Capital's AVNS Position: Q3 2025 in Review

NewSquare Capital sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 23 shares — an estimated $282 sold.

NewSquare Capital first reported a position in AVNS in Q2 2025 and held it in 1 quarter. The position peaked at $282 in Q2 2025. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

NewSquare Capital reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
NewSquare Capital sold 23 Avanos Medical shares in Q3 2025, an estimated $282.
NewSquare Capital first reported a position in Avanos Medical in Q2 2025 and held it in 1 quarter.
NewSquare Capital's Avanos Medical position peaked at $282 in Q2 2025.
276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.